Dr. Vincent Pellegrini discusses the PEPPER trial and the impact it could have on patient prophylaxis.
Originally filmed for NATF’s online support group.
Related Articles
July 2, 2020
COVID-19 Provider Resources
NATF is closely monitoring the COVID-19 pandemic and is committed to supporting you as you care for patients during this difficult…
June 30, 2020
Clot Chronicles: Direct Oral Anticoagulants (DOACs) and Obesity
Hi, my name is Dr. Christian Ruff, and I’m the Director of General Cardiology at Brigham and Women’s Hospital. I’m…
June 25, 2020
Get to Know Your Heart
The heart has two upper chambers, the right atrium and left atrium, and two lower chambers, the right and left…